No abstract available
Keywords:
AIMs; Anandamide; CB1; COX-2; Cannabinoid; ERK 1/2; LID; NF-κB; Neuroinflammation; PPAR gamma; TRPV-1; pAcH3.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Dyskinesia Agents / pharmacology*
-
Anti-Dyskinesia Agents / toxicity*
-
Arachidonic Acids / metabolism
-
Brain / drug effects
-
Brain / pathology
-
Cannabidiol / pharmacology*
-
Capsaicin / analogs & derivatives*
-
Capsaicin / pharmacology
-
Cyclooxygenase 2 / metabolism
-
Dyskinesia, Drug-Induced / drug therapy*
-
Dyskinesia, Drug-Induced / pathology
-
Dyskinesia, Drug-Induced / physiopathology
-
Endocannabinoids / metabolism
-
Extracellular Signal-Regulated MAP Kinases / metabolism
-
Histones / metabolism
-
Levodopa / toxicity*
-
Male
-
Mice, Inbred C57BL
-
NF-kappa B / metabolism
-
Oxidopamine
-
PPAR gamma / metabolism
-
Parkinsonian Disorders / drug therapy
-
Parkinsonian Disorders / pathology
-
Parkinsonian Disorders / physiopathology
-
Polyunsaturated Alkamides / metabolism
-
Receptor, Cannabinoid, CB1 / metabolism
-
TRPV Cation Channels / metabolism
-
Tyrosine 3-Monooxygenase / metabolism
Substances
-
Anti-Dyskinesia Agents
-
Arachidonic Acids
-
CNR1 protein, mouse
-
Endocannabinoids
-
Histones
-
NF-kappa B
-
PPAR gamma
-
Polyunsaturated Alkamides
-
Receptor, Cannabinoid, CB1
-
TRPV Cation Channels
-
TRPV1 protein, mouse
-
Cannabidiol
-
Levodopa
-
Oxidopamine
-
Tyrosine 3-Monooxygenase
-
Ptgs2 protein, mouse
-
Cyclooxygenase 2
-
Extracellular Signal-Regulated MAP Kinases
-
capsazepine
-
Capsaicin
-
anandamide